The physiological functions of prion protein

Experimental Cell Research

Volumn 281, Issue 1, 2002, Pages 1-8

  Wechselberger, Christian ^a   Wurm, Susanne ^a   Pfarr, Werner ^a   Höglinger, Otmar ^a  

^a Upper Austrian Research GmbH   (Austria)

Author keywords

Cellular prion protein; Interacting proteins; Pathological isoform; Physiological functions; Signal transduction cascades

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMYLOID BETA PROTEIN; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; ISOPROTEIN; PRION PROTEIN; PROTEIN PRECURSOR;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BINDING AFFINITY; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL SELECTION; CENTRAL NERVOUS SYSTEM; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; DISULFIDE BOND; HUMAN; KNOCKOUT MOUSE; NONHUMAN; PARKINSON DISEASE; PHYSICAL CHEMISTRY; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0036440530     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2002.5655     Document Type: Article

References (104)

1. Prusiner, S. B. (1993). Genetic and infectious prion diseases. Arch. Neurol. 50, 1129-1153.
2. Prusiner, S. B. (1998). Prions. Proc. Natl. Acad. Sci. USA 95, 13363-13383.
3. Pedersen, N. S., and Smith, E. (2002). Prion diseases: Epidemiology in man. APMIS 110, 14-22.
4. Mastrianni, J. A., and Roos, R. P. (2000). The prion diseases. Semin. Neurol. 20, 337-352.
5. Collins, S., McLean, C. A., and Masters, C. L. (2001). Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia, and kuru: A review of these less common human transmissible spongiform encephalopathies. J. Clin. Neurosci. 8, 387-397.
6. Sales, N., Rodolfo, K., Hassig, R., Faucheux, B., Di Giamberardino, L., and Moya, K. L. (1998). Cellular prion protein localization in rodent and primate brain. Eur. J. Neurosci. 10, 2464-2471.
7. Bolton, D. C., McKinley, M. P., and Prusiner, S. B. (1982). Identification of a protein that purifies with the scrapie prion. Science 218, 1309-1311.
8. Prusiner, S. B., Groth, D. F., Bolton, D. C., Kent, S. B., and Hood, L. E. (1984). Purification and structural studies of a major scrapie prion protein. Cell 38, 127-134.
9. Prusiner, S. B., and DeArmond, S. J. (1994). Prion diseases and neurodegeneration. Annu. Rev. Neurosci. 17, 311-339.
10. Aguzzi, A. (2000). Prion diseases, blood and the immune system: Concerns and reality. Haematologica 85, 3-10.
11. Brown, K. L., Ritchie, D. L., McBride, P. A., and Bruce, M. E. (2000). Detection of PrP in extraneural tissues. Microsc. Res. Tech. 50, 40-45.
12. Meiner, Z., Halimi, M., Polakiewicz, R. D., Prusiner, S. B., and Gabizon, R. (1992). Presence of prion protein in peripheral tissues of Libyan Jews with Creutzfeldt-Jakob disease. Neurology 42, 1355-1360.
13. Berg, L. J. (1994). Insights into the role of the immune system in prion diseases. Proc. Natl. Acad. Sci. USA 91, 429-432.
14. Perry, V. H., Cunningham, C., and Boche, D. (2002). Atypical inflammation in the central nervous system in prion disease. Curr. Opin. Neurol. 15, 349-354.
15. Brown, D. R., Herms, J., and Kretzschmar, H. A. (1994). Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment. Neuroreport 5, 2057-2060.
16. Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Jr., Baron, P., Villalba, M., Ferrari, D., and Rossi, F. (1995). Activation of microglial cells by beta-amyloid protein and interferon- gamma. Nature 374, 647-650.
17. Brown, D. R., Qin, K., Herms, J. W., Madlung, A., Manson, J., Strome, R., Fraser, P. E., Kruck, T., von Bohlen, A., Schulz-Schaeffer, W., Giese, A., Westaway, D., and Kretzschmar, H. (1997). The cellular prion protein binds copper in vivo. Nature 390, 684-687.
18. Kretzschmar, H. A., Prusiner, S. B., Stowring, L. E., and DeArmond, S. J. (1986). Scrapie prion proteins are synthesized in neurons. Am. J. Pathol. 122, 1-5.
19. Manson, J., West, J. D., Thomson, V., McBride, P., Kaufman, M. H., and Hope, J. (1992). The prion protein gene: A role in mouse embryogenesis? Development 115, 117-122.
20. Stahl, N., Borchelt, D. R., Hsiao, K., and Prusiner, S. B. (1987). Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51, 229-240.
21. Lee, I. Y., Westaway, D., Smit, A. F., Wang, K., Seto, J., Chen, L., Acharya, C., Ankener, M., Baskin, D., Cooper, C., Yao, H., Prusiner, S. B., and Hood, L. E. (1998). Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res. 8, 1022-1037.
22. Stahl, N., Baldwin, M. A., Hecker, R., Pan, K. M., Burlingame, A. L., and Prusiner, S. B. (1992). Glycosylinositol phospholipid anchors of the scrapie and cellular prion proteins contain sialic acid. Biochemistry 31, 5043-5053.
23. Rudd, P. M., Endo, T., Colominas, C., Groth, D., Wheeler, S. F., Harvey, D. J., Wormald, M. R., Serban, H., Prusiner, S. B., Kobata, A., and Dwek, R. A. (1999). Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc. Natl. Acad. Sci. USA 96, 13044-13049.
24. Caughey, B., Race, R. E., Ernst, D., Buchmeier, M. J., and Chesebro, B. (1989). Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J. Virol. 63, 175-181.
25. Rademacher, T. W., Parekh, R. B., and Dwek, R. A. (1988). Glycobiology. Annu. Rev. Biochem. 57, 785-838.
26. Walmsley, A. R., Zeng, F., and Hooper, N. M. (2001). Membrane topology influences N-glycosylation of the prion protein. EMBO J. 20, 703-712.
27. Rogers, M., Yehiely, F., Scott, M., and Prusiner, S. B. (1993). Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells. Proc. Natl. Acad. Sci. USA 90, 3182-3186.
28. Kocisko, D. A., Come, J. H., Priola, S. A., Chesebro, B., Raymond, G. J., Lansbury, P. T., and Caughey, B. (1994). Cell-free formation of protease-resistant prion protein. Nature 370, 471-474.
29. Stahl, N., and Prusiner, S. B. (1991). Prions and prion proteins. FASEB J. 5, 2799-2807.
30. Mehlhorn, I., Groth, D., Stockel, J., Moffat, B., Reilly, D., Yansura, D., Willett, W. S., Baldwin, M., Fletterick, R., Cohen, F. E., Vandlen, R., Henner, D., and Prusiner, S. B. (1996). High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 35, 5528-5537.
31. Welker, E., Wedemeyer, W. J., and Scheraga, H. A. (2001). A role for intermolecular disulfide bonds in prion diseases? Proc. Natl. Acad. Sci. USA 98, 4334-4336.
32. Welker, E., Raymond, L. D., Scheraga, H. A., and Caughey, B. (2002). Intramolecular versus intermolecular disulfide bonds in prion proteins. J. Biol. Chem. 24, 24.
33. Sparkes, R. S., Simon, M., Cohn, V. H., Fournier, R. E., Lem, J., Klisak, I., Heinzmann, C., Blatt, C., Lucero, M., Mohandas, T., et al. (1986). Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc. Natl. Acad. Sci. USA 83, 7358-7362.
34. Gabriel, J. M., Oesch, B., Kretzschmar, H., Scott, M., and Prusiner, S. B. (1992). Molecular cloning of a candidate chicken prion protein. Proc. Natl. Acad. Sci. USA 89, 9097-9101.
35. Schatzl, H. M., Da Costa, M., Taylor, L., Cohen, F. E., and Prusiner, S. B. (1995). Prion protein gene variation among primates. J. Mol. Biol. 245, 362-374.
36. Oesch, B., Westaway, D., and Prusiner, S. B. (1991). Prion protein genes: Evolutionary and functional aspects. Curr. Top. Microbiol. Immunol. 172, 109-124.
37. Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R. J., Cohen, F. E., et al. (1993). Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90, 10962-10966.
38. Eigen, M. (1996). Prionics or the kinetic basis of prion diseases. Biophys. Chem. 63, A1-18.
39. Taraboulos, A., Rogers, M., Borchelt, D. R., McKinley, M. P., Scott, M., Serban, D., and Prusiner, S. B. (1990). Acquisition of protease resistance by prion proteins in scrapie- infected cells does not require asparagine-linked glycosylation. Proc. Natl. Acad. Sci. USA 87, 8262-8266.
40. Lehmann, S., and Harris, D. A. (1997). Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J. Biol. Chem. 272, 21479-21487.
41. Oesch, B., Jensen, M., Nilsson, P., and Fogh, J. (1994). Properties of the scrapie prion protein: Quantitative analysis of protease resistance. Biochemistry 33, 5926-5931.
42. Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C., Bendheim, P. E., Groth, D. F., and Glenner, G. G. (1983). Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35, 349-358.
43. Harris, D. A. (1999). Cellular biology of prion diseases. Clin. Microbiol. Rev. 12, 429-444.
44. Marella, M., Lehmann, S., Grassi, J., and Chabry, J. (2002). Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release. J. Biol. Chem. 6, 6.
45. Taraboulos, A., Scott, M., Semenov, A., Avrahami, D., Laszlo, L., Prusiner, S. B., and Avraham, D. (1995). Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell Biol. 129, 121-132.
46. Bueler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H. P., DeArmond, S. J., Prusiner, S. B., Aguet, M., and Weissmann, C. (1992). Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582.
47. Moore, R. C., Lee, I. Y., Silverman, G. L., Harrison, P. M., Strome, R., Heinrich, C., Karunaratne, A., Pasternak, S. H., Chishti, M. A., Liang, Y., Mastrangelo, P., Wang, K., Smit, A. F., Katamine, S., Carlson, G. A., Cohen, F. E., Prusiner, S. B., Melton, D. W., Tremblay, P., Hood, L. E., and Westaway, D. (1999). Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J. Mol. Biol. 292, 797-817.
48. Tobler, I., Deboer, T., and Fischer, M. (1997). Sleep and sleep regulation in normal and prion protein-deficient mice. J. Neurosci. 17, 1869-1879.
49. Tobler, I., Gaus, S. E., Deboer, T., Achermann, P., Fischer, M., Rulicke, T., Moser, M., Oesch, B., McBride, P. A., and Manson, J. C. (1996). Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380, 639-642.
50. Colling, S. B., Collinge, J., and Jefferys, J. G. (1996). Hippocampal slices from prion protein null mice: Disrupted Ca(2+)- activated K+ currents. Neurosci. Lett. 209, 49-52.
51. Bueler, H., Aguzzi, A., Sailer, A., Greiner, R. A., Autenried, P., Aguet, M., and Weissmann, C. (1993). Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347.
52. Raeber, A. J., Sailer, A., Hegyi, I., Klein, M. A., Rulicke, T., Fischer, M., Brandner, S., Aguzzi, A., and Weissmann, C. (1999). Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication. Proc. Natl. Acad. Sci. USA 96, 3987-3992.
53. Hill, A. E., and Collinge, J. (2002). Species-barrier-independent prion replication in apparently resistant species. APMIS 110, 44-53.
54. Blattler, T. (2002). Transmission of prion disease. APMIS 110, 71-78.
55. Brown, P. (2002). Drug therapy in human and experimental transmissible spongiform encephalopathy. Neurology 58, 1720-1725.
56. Peretz, D., Williamson, R. A., Kaneko, K., Vergara, J., Leclerc, E., Schmitt-Ulms, G., Mehlhorn, I. R., Legname, G., Wormald, M. R., Rudd, P. M., Dwek, R. A., Burton, D. R., and Prusiner, S. B. (2001). Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739-743.
57. Heppner, F. L., Musahl, C., Arrighi, I., Klein, M. A., Rulicke, T., Oesch, B., Zinkernagel, R. M., Kalinke, U., and Aguzzi, A. (2001). Prevention of scrapie pathogenesis by transgenic expression of anti- prion protein antibodies. Science 294, 178-182.
58. Miele, G., Manson, J., and Clinton, M. (2001). A novel erythroid-specific marker of transmissible spongiform encephalopathies. Nat. Med. 7, 361-364.
59. Shaked, G. M., Shaked, Y., Kariv-Inbal, Z., Halimi, M., Avraham, I., and Gabizon, R. (2001). A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases. J. Biol. Chem. 276, 31479-31482.
60. Balen, A. (2002). Bye-bye urinary gonadotrophins?: Is there a risk of prion disease after the administration of urinary-derived gonadotrophins? Hum. Reprod. 17, 1676-1680.
61. Hornshaw, M. P., McDermott, J. R., and Candy, J. M. (1995). Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem. Biophys. Res. Commun. 207, 621-629.
62. Viles, J. H., Cohen, F. E., Prusiner, S. B., Goodin, D. B., Wright, P. E., and Dyson, H. J. (1999). Copper binding to the prion protein: Structural implications of four identical cooperative binding sites. Proc. Natl. Acad. Sci. USA 96, 2042-2047.
63. Rizzardini, M., Chiesa, R., Angeretti, N., Lucca, E., Salmona, M., Forloni, G., and Cantoni, L. (1997). Prion protein fragment 106-126 differentially induces heme oxygenase-1 mRNA in cultured neurons and astroglial cells. J. Neurochem. 68, 715-720.
64. Milhavet, O., and Lehmann, S. (2002). Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res. Brain Res. Rev. 38, 328-339.
65. Brown, D. R., and Besinger, A. (1998). Prion protein expression and superoxide dismutase activity. Biochem. J. 334, 423-429.
66. Waggoner, D. J., Bartnikas, T. B., and Gitlin, J. D. (1999). The role of copper in neurodegenerative disease. Neurobiol. Dis. 6, 221-230.
67. Llanos, R. M., and Mercer, J. F. (2002). The molecular basis of copper homeostasis copper-related disorders. DNA Cell Biol. 21, 259-270.
68. Graner, E., Mercadante, A. F., Zanata, S. M., Forlenza, O. V., Cabral, A. L., Veiga, S. S., Juliano, M. A., Roesler, R., Walz, R., Minetti, A., Izquierdo, I., Martins, V. R., and Brentani, R. R. (2000). Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res. Mol. Brain Res. 76, 85-92.
69. Cabral, A. L., Lee, K. S., and Martins, V. R. (2002). Regulation of the cellular prion protein gene expression depends on chromatin conformation. J. Biol. Chem. 277, 5675-5682.
70. Somerville, R. A. (1999). Host and transmissible spongiform encephalopathy agent strain control glycosylation of PrP. J. Gen. Virol. 80, 1865-1872.
71. Somerville, R. A., Chong, A., Mulqueen, O. U., Birkett, C. R., Wood, S. C., and Hope, J. (1997). Biochemical typing of scrapie strains. Nature 386, 564.
72. Farquhar, C. F., Somerville, R. A., and Bruce, M. E. (1998). Straining the prion hypothesis. Nature 391, 345-346.
73. Shyng, S. L., Huber, M. T., and Harris, D. A. (1993). A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J. Biol. Chem. 268, 15922-15928.
74. Pauly, P. C., and Harris, D. A. (1998). Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273, 33107-33110.
75. Lee, K. S., Magalhaes, A. C., Zanata, S. M., Brentani, R. R., Martins, V. R., and Prado, M. A. (2001). Internalization of mammalian fluorescent cellular prion protein and N- terminal deletion mutants in living cells. J. Neurochem. 79, 79-87.
76. Shyng, S. L., Lehmann, S., Moulder, K. L., and Harris, D. A. (1995). Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. J. Biol. Chem. 270, 30221-30229.
77. Martins, V. R., Graner, E., Garcia-Abreu, J., de Souza, S. J., Mercadante, A. F., Veiga, S. S., Zanata, S. M., Neto, V. M., and Brentani, R. R. (1997). Complementary hydropathy identifies a cellular prion protein receptor. Nat. Med. 3, 1376-1382.
78. Kristensson, K., Feuerstein, B., Taraboulos, A., Hyun, W. C., Prusiner, S. B., and DeArmond, S. J. (1993). Scrapie prions alter receptor-mediated calcium responses in cultured cells. Neurology 43, 2335-2341.
79. Fraser, S. P., Suh, Y. H., and Djamgoz, M. B. (1997). Ionic effects of the Alzheimer's disease beta-amyloid precursor protein and its metabolic fragments. Trends Neurosci. 20, 67-72.
80. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Rydel, R. E. (1992). Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
81. Kawahara, M., Kuroda, Y., Arispe, N., and Rojas, E. (2000). Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J. Biol. Chem. 275, 14077-14083.
82. Mirzabekov, T. A., Lin, M. C., and Kagan, B. L. (1996). Pore formation by the cytotoxic islet amyloid peptide amylin. J. Biol. Chem. 271, 1988-1992.
83. Arispe, N., Pollard, H. B., and Rojas, E. (1996). Zn2+ interaction with Alzheimer amyloid beta protein calcium channels. Proc. Natl. Acad. Sci. USA 93, 1710-1715.
84. Lin, M. C., Mirzabekov, T., and Kagan, B. L. (1997). Channel formation by a neurotoxic prion protein fragment. J. Biol. Chem. 272, 44-47.
85. Whatley, S. A., Powell, J. F., Politopoulou, G., Campbell, I. C., Brammer, M. J., and Percy, N. S. (1995). Regulation of intracellular free calcium levels by the cellular prion protein. Neuroreport 6, 2333-2337.
86. Herms, J. W., Tings, T., Dunker, S., and Kretzschmar, H. A. (2001). Prion protein affects Ca2+-activated K+ currents in cerebellar purkinje cells. Neurobiol. Dis. 8, 324-330.
87. Kawahara, M., and Kuroda, Y. (2000). Molecular mechanism of neurodegeneration induced by Alzheimer's beta- amyloid protein: Channel formation and disruption of calcium homeostasis. Brain Res. Bull. 53, 389-397.
88. Silei, V., Fabrizi, C., Venturini, G., Salmona, M., Bugiani, O., Tagliavini, F., and Lauro, G. M. (1999). Activation of microglial cells by PrP and beta-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels. Brain Res. 818, 168-170.
89. Gabizon, R., Meiner, Z., Halimi, M., and Ben-Sasson, S. A. (1993). Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate. J. Cell Physiol. 157, 319-325.
90. Spielhaupter, C., and Schatzl, H. M. (2001). PrPC directly interacts with proteins involved in signaling pathways. J. Biol. Chem. 276, 44604-44612.
91. Fischer, M. B., Roeckl, C., Parizek, P., Schwarz, H. P., and Aguzzi, A. (2000). Binding of disease-associated prion protein to plasminogen. Nature 408, 479-483.
92. Maissen, M., Roeckl, C., Glatzel, M., Goldmann, W., and Aguzzi, A. (2001). Plasminogen binds to disease-associated prion protein of multiple species. Lancet 357, 2026-2028.
93. Gonzalez-Iglesias, R., Pajares, M. A., Ocal, C., Carlos Espinosa, J., Oesch, B., and Gasset, M. (2002). Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges. J. Mol. Biol. 319, 527-540.
94. Martins, V. R., Mercadante, A. F., Cabral, A. L., Freitas, A. R., and Castro, R. M. (2001). Insights into the physiological function of cellular prion protein. Braz. J. Med. Biol. Res. 34, 585-595.
95. Graner, E., Mercadante, A. F., Zanata, S. M., Martins, V. R., Jay, D. G., and Brentani, R. R. (2000). Laminin-induced PC-12 cell differentiation is inhibited following laser inactivation of cellular prion protein. FEBS Lett. 482, 257-260.
96. Rieger, R., Edenhofer, F., Lasmezas, C. I., and Weiss, S. (1997). The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat. Med. 3, 1383-1388.
97. Luckenbill-Edds, L. (1997). Laminin and the mechanism of neuronal outgrowth. Brain Res. Brain Res. Rev. 23, 1-27.
98. Herms, J. W., Madlung, A., Brown, D. R., and Kretzschmar, H. A. (1997). Increase of intracellular free Ca2+ in microglia activated by prion protein fragment. Glia 21, 253-257.
99. Combs, C. K., Johnson, D. E., Cannady, S. B., Lehman, T. M., and Landreth, G. E. (1999). Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J. Neurosci. 19, 928-939.
100. Satoh, J., Kuroda, Y., and Katamine, S. (2000). Gene expression profile in prion protein-deficient fibroblasts in culture. Am. J. Pathol. 157, 59-68.
101. Oh, P., and Schnitzer, J. E. (2001). Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol. Biol. Cell 12, 685-698.
102. Clarke, G., Collins, R. A., Leavitt, B. R., Andrews, D. F., Hayden, M. R., Lumsden, C. J., and McInnes, R. R. (2000). A one-hit model of cell death in inherited neuronal degenerations. Nature 406, 195-199.
103. Kuwahara, C., Takeuchi, A. M., Nishimura, T., Haraguchi, K., Kubosaki, A., Matsumoto, Y., Saeki, K., Yokoyama, T., Itohara, S., and Onodera, T. (1999). Prions prevent neuronal cell-line death. Nature 400, 225-226.
104. Zanata, S. M., Lopes, M. H., Mercadante, A. F., Hajj, G. N., Chiarini, L. B., Nomizo, R., Freitas, A. R., Cabral, A. L., Lee, K. S., Juliano, M. A., De Oliveira, E., Jachieri, S. G., Burlingame, A., Huang, L., Linden, R., Brentani, R. R., and Martins, V. R. (2002). Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21, 3307-3316.